Today we will begin the expansion of our factory in Rosbach vor der Höhe, Frankfurt, Germany. To mark the occasion, a groundbreaking ceremony will be held at the site to coincide with International PKU day, raising awareness of this rare metabolic disorder. PKU is one of the many inborn errors of metabolism that this factory produces products for.
The project is expected to be completed in spring 2025. The expansion will help us meet the increasing demand for specialist infant formula and protein substitutes for PKU and other inborn errors of protein metabolism around the world. The brands COMIDAMED and MEVALIA, produced at the Rosbach site, are integral to our commitment to support patients and their families. The expansion will bring:
• investment of over eight million euros
• modernisation of production
• increase manufacturing volume
• more jobs at the site from 2025.
"This investment positions us for future success, enabling us to produce according to the highest quality standards. We are dedicated to meeting the needs of our customers worldwide." David Jobse, Vitaflo Commercial Director Europe
We look forward to keeping you updated as we move forward with this project. As always, we are committed to enhancing lives together through collaboration.
About Nestlé Health Science and Vitaflo (International) Limited
Nestlé Health Science, a leader in the science of nutrition, is a globally managed business unit of Nestlé. We are committed to redefining the management of health, offering an extensive portfolio of science-based consumer health, medical nutrition, pharmaceutical therapies, and vitamin and supplement brands. Our extensive research network provides the foundation for products that empower healthier lives through nutrition. Headquartered in Switzerland, we have more than 7,000 employees around the world, with products available in more than 140 countries. www.nestlehealthscience.com Vitaflo is a business unit of Nestlé Health Science with a global footprint. For over 20 years, Vitaflo has been at the forefront of developing innovative specialised clinical nutrition products for Inborn Errors of Metabolism, nutrition support and disease specific conditions.
